Amphastar Pharmaceuticals, Inc.
AMPH
$29.79
-$0.715-2.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.23% | -41.44% | 4.97% | -17.86% | 45.26% |
| Total Depreciation and Amortization | 14.80% | 8.91% | 6.35% | 6.35% | 101.47% |
| Total Amortization of Deferred Charges | -65.44% | -64.19% | -75.15% | -85.79% | -23.64% |
| Total Other Non-Cash Items | 1.04% | 220.47% | -596.37% | 470.46% | -41.21% |
| Change in Net Operating Assets | -314.53% | -130.06% | 67.88% | -27.56% | 1.85% |
| Cash from Operations | -48.50% | -36.56% | 21.62% | -6.80% | 25.83% |
| Capital Expenditure | -74.80% | -21.65% | -31.44% | -35.32% | 33.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 74.24% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.74% | -11.87% | 75.14% | -35.18% | 4,906.99% |
| Cash from Investing | 99.11% | -31.21% | 65.38% | -11.02% | 86.26% |
| Total Debt Issued | 16,616.00% | -59.77% | -- | -97.24% | -100.01% |
| Total Debt Repaid | 99.54% | 61.22% | 99.77% | 99.98% | 88.13% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1,187.18% | 9.39% | -- | 36.61% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25,400.00% | -67.46% | 104.48% | 94.38% | 100.01% |
| Cash from Financing | -181.84% | -6.80% | 28.12% | -126.34% | -102.50% |
| Foreign Exchange rate Adjustments | 847.37% | 221.65% | 95.38% | -65.79% | 13.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.56% | -45.17% | 67.98% | -97.91% | 54.91% |